Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. Stephen, O'Day, Steven J, McDermott, David F, Weber, Robert W, Weber, Jeffrey S, Sosman, Jeffrey A, Haanen, John B, Gonzalez, Rene, Robert, Caroline, Schadendorf, Dirk, Hassel, Jessica C, Akerley, Wallace, van den Eertwegh, Alfons J.M, Lutzky, Jose, Lorigan, Paul, Vaubel, Julia M, Linette, Gerald P, Hogg, David, Ottensmeier, Christian H, Lebbé, Celeste, Peschel, Christian, Quirt, Ian, Clark, Joseph I, Wolchok, Jedd D, Tian, Jason, Yellin, Michael J, Nichol, Geoffrey M, Hoos, Axel, Urba, Walter J
Published in The New England journal of medicine (19.08.2010)
Published in The New England journal of medicine (19.08.2010)
Get full text
Journal Article
A phase II multicenter study of ipilimumab with or without dacarbazine in chemotherapy-naïve patients with advanced melanoma
Hersh, Evan M., O’Day, Steven J., Powderly, John, Khan, Khuda D., Pavlick, Anna C., Cranmer, Lee D., Samlowski, Wolfram E., Nichol, Geoffrey M., Yellin, Michael J., Weber, Jeffrey S.
Published in Investigational new drugs (01.06.2011)
Published in Investigational new drugs (01.06.2011)
Get full text
Journal Article